Kyverna Therapeutics, Inc. (KYTX) has 5 open-market insider trades by 5 insiders since 2024. The most active filer is Gilead Sciences, Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 10% Owner | — | 1 | $20.0M | 2024-02-12 |
| Bain Capital Life Sciences Fund III, L.P. | 10% Owner | — | 1 | $9.9M | 2024-02-12 |
| Vida Ventures GP III, L.L.C. via Stefan Vitorovic | 10% Owner | — | 1 | $5.6M | 2024-02-12 |
| Beth C. Seidenberg | Dir | — | 1 | $2.0M | 2026-05-27 |
| Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | — | 1 | $1000K | 2025-12-18 |
| Northpond Ventures III GP, LLC | — | — | 0 | — | 2024-02-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Beth C. Seidenberg | Director | Buy | $2.0M | 2025-12-18 |
| Westlake BioPartners Opportunity Fund I, L.P. | 10% | Buy | $1000K | 2025-12-18 |
| Karen Marie Walker | CTO | Sell | $586K | 2025-12-15 |
| Vida Ventures GP III, L.L.C. | 10% Owner | Buy | $5.6M | 2024-02-12 |
| Gilead Sciences, Inc. | 10% Owner | Buy | $20.0M | 2024-02-12 |
| Bain Capital Life Sciences Fund III, L.P. | 10% Owner | Buy | $9.9M |
Companies that share insiders with KYTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-02-12 |